JPS509164B1 - - Google Patents

Info

Publication number
JPS509164B1
JPS509164B1 JP12483170A JP12483170A JPS509164B1 JP S509164 B1 JPS509164 B1 JP S509164B1 JP 12483170 A JP12483170 A JP 12483170A JP 12483170 A JP12483170 A JP 12483170A JP S509164 B1 JPS509164 B1 JP S509164B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP12483170A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP12483170A priority Critical patent/JPS509164B1/ja
Publication of JPS509164B1 publication Critical patent/JPS509164B1/ja
Pending legal-status Critical Current

Links

Landscapes

  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
JP12483170A 1970-12-29 1970-12-29 Pending JPS509164B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12483170A JPS509164B1 (en) 1970-12-29 1970-12-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12483170A JPS509164B1 (en) 1970-12-29 1970-12-29

Publications (1)

Publication Number Publication Date
JPS509164B1 true JPS509164B1 (en) 1975-04-10

Family

ID=14895162

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12483170A Pending JPS509164B1 (en) 1970-12-29 1970-12-29

Country Status (1)

Country Link
JP (1) JPS509164B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10668063B2 (en) 2015-03-06 2020-06-02 Beyondspring Pharmaceuticals, Inc. Method of treating cancer associated with a RAS mutation
US11400086B2 (en) 2017-02-01 2022-08-02 Beyondspring Pharmaceuticals, Inc. Method of reducing chemotherapy-induced neutropenia

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10668063B2 (en) 2015-03-06 2020-06-02 Beyondspring Pharmaceuticals, Inc. Method of treating cancer associated with a RAS mutation
US11400086B2 (en) 2017-02-01 2022-08-02 Beyondspring Pharmaceuticals, Inc. Method of reducing chemotherapy-induced neutropenia

Similar Documents

Publication Publication Date Title
AR204384A1 (en)
JPS509164B1 (en)
AU2044470A (en)
AU1716970A (en)
AU1833270A (en)
AU2017870A (en)
AU2085370A (en)
AU2130570A (en)
AU442396B2 (en)
AU1969370A (en)
AU2115870A (en)
AU1591370A (en)
AU1603270A (en)
AU1689770A (en)
AU1789870A (en)
AU1841070A (en)
AU1872870A (en)
AU2130770A (en)
AU1943370A (en)
AU1918570A (en)
AU1974970A (en)
AU2061170A (en)
AU2144270A (en)
AU2131570A (en)
AU1879170A (en)